Mira Pharmaceuticals (MIRA) Common Equity (2022 - 2026)
Mira Pharmaceuticals (MIRA) recorded Common Equity of $9.35 million in the quarter ended Mar 31, 2026, up 622.4% from $1.29 million a year earlier but down 10.0% from the prior quarter.
Mira Pharmaceuticals (MIRA) Common Equity (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Mira Pharmaceuticals reported Common Equity of $10.39 million, up 372.4% from the prior year.
- Across earlier years, Common Equity came in at $2.2 million in the year ended Dec 31, 2024 (-49.7%), $4.37 million in the year ended Dec 31, 2023 and -$596,232 in the year ended Dec 31, 2022.
- Quarterly Common Equity has ranged from -$1.79 million in the quarter ended Mar 31, 2023 to $10.39 million in the quarter ended Dec 31, 2025 over the past five years.
- On a year-over-year basis, Common Equity has increased for three consecutive quarters, with growth averaging 119.1% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 622.4% in the quarter ended Mar 31, 2026, against a decline of 74.3% in the quarter ended Jun 30, 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.39 million (quarter ended Dec 31, 2025), $7.55 million (quarter ended Sep 30, 2025) and $569,859 (quarter ended Jun 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Mira Pharmaceuticals | 26.05 Mn | -10.02 Mn | - | 8.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.16 Mn |
| Mar 31, 2026 | 9.35 Mn |
| Dec 31, 2025 | 10.39 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 569,859.00 |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 8.12 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | -596,232.00 |
| Sep 30, 2022 | 320,449.00 |
| Jun 30, 2022 | 1.08 Mn |
Mira Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MIRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MIRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MIRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();